Word: hoffmann
(lookup in dictionary)
(lookup stats)
Dates: all
Sort By: most recent first
(reverse)
...Stanley Hoffmann...
...list of corporations that ask all job applicants to undergo urinalysis is like a roll call of the largest and most prestigious firms in the U.S. Among them: Exxon, IBM, Lockheed, Shearson Lehman, Federal Express, United Airlines, TWA, Hoffmann-La Roche, the New York Times. On March 1, Du Pont became the newest name on the list. And this spring, AT&T, which already tests applicants at plants where volatile chemicals are handled, will start screening all potential employees at its manufacturing facilities for drug use. About one-fourth of the FORTUNE 500 companies now screen applicants for drugs...
...perhaps Bok also forgets that "threatening freedom of speech" flips both ways. Refusing to divest, snapping back at Faculty members like Stanley Hoffmann, Dillon Professor of the Civilization of France, at Faculty meetings, and refusing to speak to students at an open forum also threaten freedom of speech. Bok has clearly told pro-divestment activists that he does not believe them, that in fact he thinks they are crazy reactionaries...
Drug companies offer anxious Americans a host of tranquilizers, but none is more popular than Valium, the country's fourth-best-selling prescription drug. Until its patent expired last February, Hoffmann-La Roche, a Swiss firm, , enjoyed a monopoly in manufacturing Valium. Last week that profitable preserve was spoiled when three pharmaceutical companies received approval from the Food and Drug Administration to begin marketing the medicine under its generic name, diazepam...
...produce the tranquilizer, but permission has so far been granted only to Zenith Laboratories, Mylan Laboratories and the Parke-Davis division of Warner-Lambert. Diazepam is expected to sell for up to 50% less than Valium. One hundred 5-mg tablets of the tranquilizer now cost around $25. Hoffmann-La Roche could lose 50% of its market share within three years. Says Zenith President James Leonard: "Consumers won't pay for a trademark. They are more interested in therapeutic value...